Lataa...
Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease
The effect of early-onset enzyme replacement therapy on renal morphologic features in Fabry disease is largely unknown. Here, we evaluated the effect of 5 years of treatment with agalsidase alfa or agalsidase beta in 12 consecutive patients age 7–33 years (median age, 16.5 years). We performed renal...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Nephrology
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3537211/ https://ncbi.nlm.nih.gov/pubmed/23274955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2012030316 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|